Peter Horby couldn’t believe his eyes.
He’d just gotten his first glimpse of new data from the United Kingdom’s Recovery Trial, an experiment enrolling tens of thousands of patients at dozens of hospitals for clinical trials investigating Covid-19 therapies.
Read Full Article »
